Drugs / Gammimmune N
last change Dec 1997 re-read 3 minutes ago

Gammimmune N

Developed for
optic neuritis
Investigated by
National Eye Institute (NEI)

Trials 1

199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00000117 Aug 1995 → Dec 1997 optic neuritis National Eye Institute (NEI) Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Gammimmune N “One group of patients received 0.4 g/kg Gammimmune N intravenously daily for 5 days, and thereafter once a month for 3 months (total: eight infusions).” NCT00000117 ↗
Route Intravenous “Gammimmune N intravenously” NCT00000117 ↗